Genomic profiling in high hyperdiploid acute myeloid leukemia: A retrospective study of 19 cases

Cancer Genetics

Volumn 204, Issue 9, 2011, Pages 516-521

  Veigaard, Christopher ^a   Nørgaard, Jan Maxwell ^a   Kjeldsen, Eigil ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Acute myeloid leukemia; Array based comparative genomic hybridization; Genomic profiling; Hyperdiploidy

Indexed keywords

ZINC FINGER PROTEIN;

ACUTE GRANULOCYTIC LEUKEMIA; ARTICLE; CANCER CLASSIFICATION; CARCINOGENESIS; CHROMOSOME 15Q; CHROMOSOME 18P; CHROMOSOME 18Q; CHROMOSOME 19P; CHROMOSOME 5Q; CHROMOSOME ABERRATION; CLINICAL ARTICLE; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; DISEASE ACTIVITY; GENE DELETION; GENE DOSAGE; GENE LOCATION; GENOME ANALYSIS; HUMAN; KARYOTYPE; L3MBTL4 GENE; MICROARRAY ANALYSIS; MOLECULAR PATHOLOGY; PLOIDY; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN LOCALIZATION; RETROSPECTIVE STUDY; TUMOR SUPPRESSOR GENE; CHROMOSOME 19; CHROMOSOME 21; CHROMOSOME 8; DIPLOIDY; GENETICS; GENOMICS;

ABNORMAL KARYOTYPE; CHROMOSOMES, HUMAN, PAIR 19; CHROMOSOMES, HUMAN, PAIR 21; CHROMOSOMES, HUMAN, PAIR 8; COMPARATIVE GENOMIC HYBRIDIZATION; DIPLOIDY; GENOMICS; HUMANS; LEUKEMIA, MYELOID, ACUTE; RETROSPECTIVE STUDIES; SEQUENCE DELETION;

EID: 84856005158     PISSN: 22107762     EISSN: 22107770     Source Type: Journal    
DOI: 10.1016/j.cancergen.2011.09.002     Document Type: Article

References (29)

1. Mrozek K., Heerema N.A., Bloomfield C.D. Cytogenetics in acute leukemia. Blood Rev 2004, 18:115-136.
2. Grimwade D., Hills R.K., Moorman A.V., et al. Refinement of cytogenetic classification in acute myeloid leukemia: determination of prognostic significance of rare recurring chromosomal abnormalities amongst 5,876 younger adult patients treated in the UK Medical Research Council trials. Blood 2010, 116:354-365. National Cancer Research Institute Adult Leukaemia Working Group.
3. Byrd J.C., Mrozek K., Dodge R.K., et al. Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B (CALGB 8461). Blood 2002, 100:4325-4336.
4. Slovak M.L., Kopecky K.J., Cassileth P.A., et al. Karyotypic analysis predicts outcome of preremission and postremission therapy in adult acute myeloid leukemia: a Southwest Oncology Group/Eastern Cooperative Oncology Group Study. Blood 2000, 96:4075-4083.
5. Schoch C., Haferlach T., Haase D., et al. Patients with de novo acute myeloid leukaemia and complex karyotype aberrations show a poor prognosis despite intensive treatment: a study of 90 patients. Br J Haematol 2001, 112:118-126.
6. Schoch C., Haferlach T., Bursch S., et al. Loss of genetic material is more common than gain in acute myeloid leukemia with complex aberrant karyotype: a detailed analysis of 125 cases using conventional chromosome analysis and fluorescence in situ hybridization including 24-color FISH. Genes Chromosomes Cancer 2002, 35:20-29.
7. Grimwade D., Walker H., Oliver F., et al. The importance of diagnostic cytogenetics on outcome in AML: analysis of 1,612 patients entered into the MRC AML 10 trial. Blood 1998, 92:2322-2333. The Medical Research Council Adult and Children's Leukaemia Working Parties.
8. Luquet I., Lai J.L., Barin C., et al. Hyperdiploid karyotypes in acute myeloid leukemia define a novel entity: a study of 38 patients from the Groupe Francophone de Cytogenetique Hematologique (GFCH). Leukemia 2008, 22:132-137.
9. Iyer R.V., Sait S.N., Matsui S., et al. Massive hyperdiploidy and tetraploidy in acute myelocytic leukemia and myelodysplastic syndrome. Cancer Genet Cytogenet 2004, 148:29-34.
10. Gupta M., Raghavan M., Gale R.E., et al. Novel regions of acquired uniparental disomy discovered in acute myeloid leukemia. Genes Chromosomes Cancer 2008, 47:729-739.
11. Heinrichs S., Li C., Look A.T. SNP array analysis in hematologic malignancies: avoiding false discoveries. Blood 2010, 115:4157-4161.
12. Walter M.J., Payton J.E., Ries R.E., et al. Acquired copy number alterations in adult acute myeloid leukemia genomes. Proc Natl Acad Sci U S A 2009, 106:12950-12955.
13. Strefford J.C., Parker H. Array-based comparative genomic hybridization as a tool for analyzing the leukemia genome. Methods Mol Biol 2009, 538:151-177.
14. Paulsson K., Heidenblad M., Morse H., et al. Identification of cryptic aberrations and characterization of translocation breakpoints using array CGH in high hyperdiploid childhood acute lymphoblastic leukemia. Leukemia 2006, 20:2002-2007.
15. Strefford J.C., Worley H., Barber K., et al. Genome complexity in acute lymphoblastic leukemia is revealed by array-based comparative genomic hybridization. Oncogene 2007, 26:4306-4318.
16. Rabin K.R., Man T.K., Yu A., et al. Clinical utility of array comparative genomic hybridization for detection of chromosomal abnormalities in pediatric acute lymphoblastic leukemia. Pediatr Blood Cancer 2008, 51:171-177.
17. Rucker F.G., Bullinger L., Schwaenen C., et al. Disclosure of candidate genes in acute myeloid leukemia with complex karyotypes using microarray-based molecular characterization. J Clin Oncol 2006, 24:3887-3894.
18. Martinez-Ramirez A., Urioste M., Melchor L., et al. Analysis of myelodysplastic syndromes with complex karyotypes by high-resolution comparative genomic hybridization and subtelomeric CGH array. Genes Chromosomes Cancer 2005, 42:287-298.
19. Kjeldsen E., Tordrup D., Hubner G.M., et al. Topoisomerase I deficiency results in chromosomal alterations in cervical cancer cells. Anticancer Res 2010, 30:3257-3265.
20. Kent W.J., Sugnet C.W., Furey T.S., et al. The human genome browser at UCSC. Genome Res 2002, 12:996-1006.
21. Schoch C., Kern W., Kohlmann A., et al. Acute myeloid leukemia with a complex aberrant karyotype is a distinct biological entity characterized by genomic imbalances and a specific gene expression profile. Genes Chromosomes Cancer 2005, 43:227-238.
22. Addou-Klouche L., Adelaide J., Finetti P., et al. Loss, mutation and deregulation of L3MBTL4 in breast cancers. Mol Cancer 2010, 9:213.
23. Woyach J.A., Heerema N.A., Zhao J., et al. Dic(17;18)(p11.2;p11.2) is a recurring abnormality in chronic lymphocytic leukaemia associated with aggressive disease. Br J Haematol 2010, 148:754-759.
24. John L.B., Ward A.C. The Ikaros gene family: transcriptional regulators of hematopoiesis and immunity. Mol Immunol 2011, 48:1272-1278.
25. Iafrate A.J., Feuk L., Rivera M.N., et al. Detection of large-scale variation in the human genome. Nat Genet 2004, 36:949-951.
26. Alvarez S., Cigudosa J.C. Gains, losses and complex karyotypes in myeloid disorders: a light at the end of the tunnel. Hematol Oncol 2005, 23:18-25.
27. Poppe B., Vandesompele J., Schoch C., et al. Expression analyses identify MLL as a prominent target of 11q23 amplification and support an etiologic role for MLL gain of function in myeloid malignancies. Blood 2004, 103:229-235.
28. Schoch C., Kohlmann A., Dugas M., et al. Genomic gains and losses influence expression levels of genes located within the affected regions: a study on acute myeloid leukemias with trisomy 8, 11, or 13, monosomy 7, or deletion 5q. Leukemia 2005, 19:1224-1228.
29. Paulsson K., Haferlach C., Fonatsch C., et al. The idic(X)(q13) in myeloid malignancies: breakpoint clustering in segmental duplications and association with TET2 mutations. Hum Mol Genet 2010, 19:1507-1514.